Mitochondrial Metabolism as a Target for Cancer Therapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32668195.
- Also identified by DOI 10.1016/j.cmet.2020.06.019 and PMC identifier 7483781.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent evidence in humans and mice supports the notion that mitochondrial metabolism is active and necessary for tumor growth. Mitochondrial metabolism supports tumor anabolism by providing key metabolites for macromolecule synthesis and generating oncometabolites to maintain the cancer phenotype. Moreover, there are multiple clinical trials testing the efficacy of inhibiting mitochondrial metabolism as a new cancer therapeutic treatment. In this review, we discuss the rationale of using these anti-cancer agents in clinical trials and highlight how to effectively utilize them in different tumor contexts.
Medical subject headings
- Antineoplastic Agents
- Mitochondria
- Neoplasms